Please assess the completion status of the following clinical trial:

Trial Title: A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must have Stage 3B or 4 Non-Small Cell Lung Cancer of the non- squamous type~* Patients must at least be able to be physically mobile, take care of yourself and be able to perform light activities such as light housework or office work~* Patients must not have had previous chemotherapy treatment for lung cancer~* Patients must not have had radiotherapy in the last 30 days~* Patients must have measureable tumor lesions according to the Response Evaluation Criteria in Solid Tumors (RECIST) guidelines or disease that can be evaluated on computed tomography (CT) scan~* Patients' test results assessing the function of their blood forming tissue, kidneys, liver and lungs are satisfactory~* Women must be sterile, postmenopausal or on contraception and men must be sterile or on contraception~Exclusion Criteria:~* Patients cannot have received other investigational drugs within the last 30 days~* Patients cannot have any serious, uncontrolled medical condition that might compromise their ability to take part in the study safely~* Patients cannot have a current second primary malignant tumor~* Patients cannot be having current treatment with any other anti-tumor therapy~* Patients cannot have had a yellow fever vaccination within 30 days of enrolment~* Patients who are unable to take vitamins (including injections of vitamin B12) or oral cortisone medication~* Patients who are unable to stop taking more than 1.3 grams of aspirin on a daily basis or non-steroidal anti-inflammatory agents~* Patients who are pregnant or breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pemetrexed (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).